Q4 2014 Holdings
Filed 2015-02-17 | 24 holdings | $116.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| ANI Pharmaceuticals Inc(ANIP) | COM | 00182C103 | $61.5M | 1,090,067 | 52.6% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $45.0M | 687,900 | 38.5% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $9.8M | 877,407 | 8.4% |
| Enanta Pharmaceuticals Inc(ENTA) | COM | 29251M106 | $86.2K | 1,696,147 | 0.1% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $85.5K | 660,186 | 0.1% |
| Cardiovascular SYS Inc del(CSIIEUR) | COM | 141619106 | $64.2K | 2,135,200 | 0.1% |
| Akorn Inc(AKRXEUR) | COM | 009728106 | $60.9K | 1,683,485 | 0.1% |
| Insys Therapeutics Inc New | COM NEW | 45824V209 | $52.9K | 1,254,247 | 0.0% |
| Anacor Pharmaceuticals Inc | COM | 032420101 | $47.4K | 1,469,690 | 0.0% |
| Orthofix Intl N V | COM | N6748L102 | $43.2K | 1,436,495 | 0.0% |
| Pernix Therapeutics Hldgs in | COM | 71426V108 | $32.2K | 3,427,789 | 0.0% |
| Retrophin Inc | COM | 761299106 | $31.2K | 2,551,535 | 0.0% |
| Hyperion Therapeutics Inc | COM | 44915N101 | $30.0K | 1,251,353 | 0.0% |
| Osiris Therapeutics Inc New | COM | 68827R108 | $26.8K | 1,674,561 | 0.0% |
| Healthways Inc | COM | 422245100 | $26.2K | 1,316,493 | 0.0% |
| Derma Sciences Inc | COM PAR $.01 | 249827502 | $15.2K | 1,632,627 | 0.0% |
| Healthstream Inc(HSTM) | COM | 42222N103 | $9.5K | 321,026 | 0.0% |
| Protalix Biotherapeutics Inc | COM | 74365A101 | $9.3K | 5,077,338 | 0.0% |
| Everyday Health Inc | COM | 300415106 | $9.3K | 633,150 | 0.0% |
| Bioscrip Inc(BIOSEUR) | COM | 09069N108 | $8.2K | 1,177,145 | 0.0% |
| Vericel Corp(VCEL) | COM | 92346J108 | $7.2K | 2,352,940 | 0.0% |
| HMS Hldgs Corp(HMSY) | COM | 40425J101 | $6.3K | 299,246 | 0.0% |
| Biotime Inc(BTXUSD) | COM | 09066L105 | $6.0K | 1,602,550 | 0.0% |
| Merus Labs Intl Inc New | COM | 59047R101 | $2.2K | 1,360,214 | 0.0% |